
“Pulmocide is very aware of the growing concern around Candida auris and we are delighted to be able to contribute to the growing body of research characterising this newly identified pathogen.” CEO Dr Garth Rapeport. Full paper snip.ly/s2bl7o PR: snip.ly/jomu2b
English



